Literature DB >> 6458145

Effect of cyproterone/acetate (SH-714) on plasma prolactin in patients with prostatic cancer.

G Holub, G Lunglmayr, J Spona.   

Abstract

Plasma prolactin was measured in 10 patients with prostatic cancer during treatment with cyproterone acetate (300 mg/week i.m.) Prolactin was assayed during a six month period at weekly intervals during the first 4 weeks and then at monthly intervals. Orchiectomy was not carried out. After 6 months prolactin levels were elevated compared with pre-treatment levels. It is concluded from this study that cyproterone acetate interferes with prolactin secretion by the pituitary gland.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6458145     DOI: 10.1007/bf00256895

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  13 in total

1.  PITUITARY FACTORS INFLUENCING GROWTH OF THE PROSTATE.

Authors:  J T GRAYHACK
Journal:  Natl Cancer Inst Monogr       Date:  1963-10

2.  Longitudinal study of the behaviour of certain hormonal parameters in women undergoing treatment with cyproterone acetate.

Authors:  M Giusti; F Parazzi; A Reitano; F Bolognesi; G Giordano
Journal:  Acta Eur Fertil       Date:  1977-09

3.  Prolaction and prostate cancer.

Authors:  W E Farnsworth; M J Gonder
Journal:  Urology       Date:  1977-07       Impact factor: 2.649

4.  Hyperprolactinemia in girls with idiopathic precocious puberty under prolonged treatment with cyproterone acetate.

Authors:  D Fonzo; A Angeli; R Sivieri; S Andriolo; R Frajria; F Ceresa
Journal:  J Clin Endocrinol Metab       Date:  1977-07       Impact factor: 5.958

5.  Plasma steroid and protein hormone concentrations in patients with prostatic carcinoma, before and during oestrogen therapy.

Authors:  M E Harper; W B Peeling; T Cowley; B G Brownsey; M E Phillips; G Groom; D R Fahmy; K Griffiths
Journal:  Acta Endocrinol (Copenh)       Date:  1976-02

6.  Mechanism of androgenic action: effect of specific intracellular inhibitors.

Authors:  P C Walsh; S G Korenman
Journal:  J Urol       Date:  1971-06       Impact factor: 7.450

7.  The hormonal effects of antiandrogen (SH-714) treatment in man.

Authors:  R Schoonees; D S Schalch; G P Murphy
Journal:  Invest Urol       Date:  1971-05

8.  Sex hormone binding globulin binding capacity, testosterone, 5alpha-dihydrotestosterone, oestradiol and prolactin in plasma of patients with prostatic carcinoma under various types of hormonal treatment.

Authors:  W Bartsch; H J Horst; H Becker; G Nehse
Journal:  Acta Endocrinol (Copenh)       Date:  1977-07

9.  Circadian periodicity of serum prolactin concentration in man.

Authors:  J Nokin; M Vekemans; M L'Hermite; C Robyn
Journal:  Br Med J       Date:  1972-09-02

10.  Role of lactogen in prostatic physiology.

Authors:  W E Farnsworth
Journal:  Urol Res       Date:  1975-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.